Assignee
PROGENRA INC
US4 patents
Top patents by PatentIndex Score
US9717717B1Aug 1, 2017
Methods of treating cancer through the inhibition of USP7 and immune system modulation
PROGENRA INC9 citations80
US7842460B2Nov 30, 2010
Method for assessing proteolytic enzyme activity using ubiquitin fusion substrate
PROGENRA INC7 citations63
US11273154B2Mar 15, 2022
Azole compounds as ubiquitin-specific protease USP7 inhibitors
PROGENRA INC0 citations60
US10292973B2May 21, 2019
Covalent irreversible inhibitors of USP7 as anti-cancer agents
PROGENRA INC0 citations48